Valentine Capital Asset Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
U
MG
NCM
HF
Valentine Capital Asset Management's XPH Position: Q1 2014 in Review
Valentine Capital Asset Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2014, closing a stake of 13,970 shares — an estimated $614K sold.
Valentine Capital Asset Management first reported a position in XPH in Q2 2013 and held it in 3 quarters. The position peaked at $614K in Q4 2013. 72 funds tracked by Wall St. Rank hold XPH as of Q1 2014.
- Valentine Capital Asset Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2014 after selling out during the quarter.
- Valentine Capital Asset Management sold 13,970 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2014, an estimated $614K.
- Valentine Capital Asset Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 3 quarters.
- Valentine Capital Asset Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $614K in Q4 2013.
- 72 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2014.
Based on Valentine Capital Asset Management's 13F filing for Q1 2014, filed 16 Mar 2015.